Quest Diagnostics Director Timothy C. Wentworth Acquires Phantom Stock Units
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Quest Diagnostics Inc ($DGX): Director Timothy C. Wentworth acquired 135 Phantom Stock Units via elective fee deferral on 2026-10-01, bringing total holdings to 477 units.
Comprehensive Analysis
Insider Transaction Summary
- Insider: Timothy C. Wentworth
- Role: Director
- Company: Quest Diagnostics Inc ($DGX)
- Transaction Date: October 1, 2026
- Filing Date: October 2, 2026
- Security: Phantom Stock Units
- Transaction Type: Acquisition (Code: A)
- Shares Acquired: 135
- Price Per Share: $0.00
- Post-Transaction Holdings: 477 Phantom Stock Units
Key Notes
According to the filing footnotes, the phantom stock units resulted from an elective deferral of director cash compensation under the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors. The units are payable in cash upon termination of service as a director.
Significance
This transaction is categorized as Low significance. It reflects standard director compensation deferrals into phantom stock rather than an open-market purchase or discretionary trading action.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.